Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palmitoleic Acid Combined With Infliximab in Crohn's Disease
NCT07417696Phase 4Not yet recruiting
- Sponsor
- Chinese Medical Association
- Start
- Apr 2026
- Primary completion
- Mar 2029
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of palmitoleic acid in Crohn's disease, sponsored by Chinese Medical Association. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
palmitoleic acid
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT07417696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07417696.